NewGenIvf Group Price To Sales Ratio Over Time
| NIVFW Stock | 0.05 0.01 18.50% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out NewGenIvf Group Performance and NewGenIvf Group Correlation. NewGenIvf |
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare NewGenIvf Group and related stocks such as Fresenius Medical Care, Regional Health Prop, and Oncology Institute Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FMS | 1.4118 | 1.61 | 1.52 | 1.4856 | 1.4253 | 1.5322 | 1.4392 | 1.5031 | 1.0465 | 0.5688 | 0.5599 | 0.4746 | 0.2307 | 0.29 | 0.28 |
| RHE | 0.1032 | 0.0693 | 0.0655 | 0.0672 | 0.0928 | 1.0693 | 0.7277 | 0.1336 | 0.1186 | 0.1174 | 0.3438 | 0.293 | 0.1641 | 0.222 | 0.18 |
| TOI | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 4.0226 | 3.4049 | 3.181 | 0.4757 | 0.464 | 0.44 |
| TOIIW | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 2.4644 | 4.0226 | 3.4049 | 3.181 | 0.4757 | 0.464 | 0.44 |
| PACS | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 2.9604 | 1.4259 | 1.1099 | 2.01 |
| ARDT | 1.1156 | 1.1156 | 1.1156 | 1.1156 | 1.1156 | 1.1156 | 1.0754 | 0.7541 | 0.544 | 0.4724 | 0.4724 | 0.4724 | 0.4485 | 0.4253 | 0.76 |
| AUNA | 1.596 | 1.596 | 1.596 | 1.596 | 1.596 | 1.596 | 1.596 | 1.596 | 1.4003 | 0.9886 | 0.9886 | 0.9886 | 0.9886 | 1.14 | 1.46 |
NewGenIvf Group and related stocks such as Fresenius Medical Care, Regional Health Prop, and Oncology Institute Price To Sales Ratio description
Price to Sales Ratio is figured by comparing NewGenIvf Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on NewGenIvf Group sales, a figure that is much harder to manipulate than other NewGenIvf Group Limited multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| NewGenIvf Group Limited | NIVFW |
Specialization | Healthcare, Medical Care Facilities |
| Exchange | NASDAQ Exchange |
null 0.0474
Additional Tools for NewGenIvf Stock Analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.